Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc
March 12, 2019 09:00 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., March 12, 2019 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics,...
Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer
November 26, 2018 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics,...
Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating That Lyopreservation Method Developed for Living Tissues is an Alternative to Cryopreservation with the Convenience of Ambient Storage
October 02, 2018 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics,...
Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018
September 17, 2018 17:00 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics,...
Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018
August 01, 2018 08:00 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics,...